RETINOSTAT Trademark

Trademark Overview

On Wednesday, June 11, 2003, a trademark application was filed for RETINOSTAT with the United States Patent and Trademark Office. The USPTO has given the RETINOSTAT trademark a serial number of 78260879. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 23, 2019. This trademark is owned by Oxford BioMedica plc. The RETINOSTAT trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical and biochemical products for use in gene delivery technology, namely, enzymes; chemical products for in-vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology

Gene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of [ blood disorders, cancers, diseases of the nervous system, ] macular degeneration, diabetic retinopathy, [ diabetes, inflammatory and auto-immune diseases, vascular disorders, ] disorders arising from improper vascularisation and single gene disorders; pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies, vector production technologies and neurogenomics products; chemical products for use in medical science, particularly for treatment of disease of the eye, vascular and neovascularisation disorders and retinopathy; pharmaceutical and biochemical preparations for the treatment of macular degeneration and retinopathy [ and...

Scientific and medical research and development; [ engineering services, biotechnology services, namely, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; ] advisory services relating to the research and development of gene therapy; consultation services in the fields of medical and scientific research in the field of professional gene therapy [; medical research and development in the field of vector production technologies ]

General Information

Serial Number78260879
Word MarkRETINOSTAT
Filing DateWednesday, June 11, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 23, 2019
Registration Number3372819
Registration DateTuesday, January 22, 2008
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 10, 2007

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemical and biochemical products for use in gene delivery technology, namely, enzymes; chemical products for in-vitro use in laboratories and for analysis in gene delivery technology, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
Goods and ServicesGene therapy and prophylaxis products, namely, gene delivery, gene transfer, gene regulation and gene modulation for the treatment of [ blood disorders, cancers, diseases of the nervous system, ] macular degeneration, diabetic retinopathy, [ diabetes, inflammatory and auto-immune diseases, vascular disorders, ] disorders arising from improper vascularisation and single gene disorders; pharmaceutical substances and preparations for use in the medical industry, namely, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations, all for use in gene delivery technologies, vector production technologies and neurogenomics products; chemical products for use in medical science, particularly for treatment of disease of the eye, vascular and neovascularisation disorders and retinopathy; pharmaceutical and biochemical preparations for the treatment of macular degeneration and retinopathy [ and angiogenesis; ] instruments and apparatus for the administration of gene and [ antibody-based ] therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes
Goods and ServicesScientific and medical research and development; [ engineering services, biotechnology services, namely, biotechnology research in the development of therapeutic and prophylactic products and vaccines; licensing of intellectual property; ] advisory services relating to the research and development of gene therapy; consultation services in the fields of medical and scientific research in the field of professional gene therapy [; medical research and development in the field of vector production technologies ]

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 23, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 23, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOxford BioMedica plc
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB
Party NameOxford BioMedica plc
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB
Party NameOxford BioMedica plc
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Trademark Events

Event DateEvent Description
Friday, August 23, 2019CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, March 23, 2017REGISTERED - SEC. 7 REQUEST ABANDONED
Sunday, January 22, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, March 14, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 14, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 4, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 4, 2014POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Friday, February 28, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 27, 2014REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Wednesday, February 26, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 10, 2014TEAS SECTION 7 REQUEST RECEIVED
Monday, February 10, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 3, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, February 3, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 22, 2014REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, February 3, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 22, 2014TEAS SECTION 8 & 15 RECEIVED
Wednesday, January 22, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 22, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 22, 2008REGISTERED-PRINCIPAL REGISTER
Wednesday, December 19, 20071(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, July 18, 2007NOTICE OF ALLOWANCE CANCELLED
Wednesday, July 18, 2007TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 3, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2007PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2007NOTICE OF PUBLICATION
Monday, February 26, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 26, 2007ASSIGNED TO LIE
Monday, January 22, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 19, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 18, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 18, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 21, 2006NON-FINAL ACTION MAILED
Thursday, July 20, 2006NON-FINAL ACTION WRITTEN
Thursday, July 20, 2006ASSIGNED TO EXAMINER
Thursday, July 13, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, July 13, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 11, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 11, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 2, 2006WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, May 12, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 5, 2006ASSIGNED TO LIE
Monday, May 1, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 21, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 20, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 28, 2006NON-FINAL ACTION MAILED
Tuesday, February 28, 2006NON-FINAL ACTION WRITTEN
Tuesday, February 21, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, February 9, 2006WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, January 20, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 13, 2006ASSIGNED TO LIE
Monday, January 9, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 7, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 4, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 4, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 26, 2005CORRESPONDENCE MAILED
Wednesday, October 26, 2005PRIORITY ACTION WRITTEN
Monday, October 3, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, September 19, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 19, 2005PAPER RECEIVED
Thursday, August 4, 2005LETTER OF SUSPENSION MAILED
Thursday, August 4, 2005SUSPENSION LETTER WRITTEN
Wednesday, August 3, 2005AMENDMENT FROM APPLICANT ENTERED
Friday, July 22, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 22, 2005PAPER RECEIVED
Monday, January 31, 2005FAX SENT
Friday, January 28, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 19, 2005INQUIRY TO SUSPENSION E-MAILED
Wednesday, January 19, 2005SUSPENSION INQUIRY WRITTEN
Monday, July 19, 2004LETTER OF SUSPENSION E-MAILED
Monday, June 21, 2004TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 21, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 21, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, June 21, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 21, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 22, 2003NON-FINAL ACTION E-MAILED
Thursday, December 18, 2003ASSIGNED TO EXAMINER
Wednesday, July 2, 2003PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, July 2, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 2, 2003TEAS VOLUNTARY AMENDMENT RECEIVED

Related Keywords

retinostat gene products research disorders delivery medical services vector preparations development